title: Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma.
authors: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
authors: Federico
authors: F
authors: Fallanca
authors: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.|Nuclear Medicine Unit, Department of Radiological Sciences, San Raffaele G. Giglio Institute, Cefalù, Italy.
authors: Pierpaolo
authors: P
authors: Alongi
authors: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
authors: Elena
authors: E
authors: Incerti
authors: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
authors: Luigi
authors: L
authors: Gianolli
authors: Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
authors: Maria
authors: M
authors: Picchio
authors: University College London Hospital, London, UK.
authors: Irfan
authors: I
authors: Kayani
authors: University College London Hospital, London, UK. jamshed.bomanji@nhs.net.|Department of Nuclear Medicine, University College Hospitals NHS Foundation Trust, 235 Euston Rd, London, NW1 2BU, UK. jamshed.bomanji@nhs.net.
authors: Jamshed B
authors: JB
authors: Bomanji
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging* / Q000628:therapy*; D017063:Outcome Assessment, Health Care / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18